Average Co-Inventor Count = 2.53
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (7 from 2,285 patents)
2. Allergan Sales, Inc. (1 from 228 patents)
8 patents:
1. 10493082 - 4-pregenen-11β-17-21-triol-3,20-dione derivatives
2. 10188667 - Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives
3. 9717743 - Pharmaceutical compositions and methods of use of 4-pregenen-11β-17-21-triol-3,20-dione derivatives
4. 9433631 - 4-pregenen-11β-17-21-triol-3,20-dione derivatives
5. 8906892 - 4-pregenen-11β-17-21-triol-3,20-dione derivatives
6. 8865691 - Pharmaceutical compositions and methods of use 4-pregenen-11β-17-21-triol-3,20-dione derivatives
7. 6903121 - TREATMENT OF TUMORS WITH ACETYLENES DISUBSTITUTED WITH A PHENYL OR HETEROAROMATIC GROUP AND A SUBSTITUTED CHROMANYL, THIOCHROMANYL OR TETRAHYDROQUINOLINYL GROUP IN COMBINATION WITH OTHER ANTI-TUMOR AGENTS
8. 6387950 - Treatment of tumors with RAR&agr; selective retinoid compounds in combination with other anti-tumor agents